The independent investigation resulted in a report published in April 2016 – link - which was communicated to the 27 CEOs together with a letter asking for further confirmation regarding their business relations with suppliers in these areas. The report was also sent to the industry led Pharmaceutical Supply Chain Initiative. The company response rate was significantly higher this time. According to the Chairman of PSCI, our engagement has created influence in the industry and during 2016 pharrma companies Sanofi, Teva, Catalent and DSM joined the PSCI
In April 2016, Nordea was invited to attend the Pharmaceutical Supply Chain Initiative annual meeting to present our expectations. At the PSCI meeting companies agreed that industry level commitment and action in order to achieve structural change is necessary. A number of companies have already confirmed that they are taking direct action with suppliers and discussions on action on industry level is underway. We are following up on this with regular meetings with PSCI and companies.
In February 2017 we presented our expectations at a pharma conference in India with international and Indian pharma companies attending. We are following up on this during Q2.